Compulsory drug detention exposure is associated with not receiving antiretroviral treatment among people who inject drugs in Bangkok, Thailand: a cross-sectional study

Substance Abuse Treatment, Prevention, and Policy

Thomas Kerr²  Julio S G Montaner²  Evan Wood²  Paisan Suwannawong⁴  Karyn Kaplan⁴  Anchalee Avihingsanon¹  Lianping Ti³  Kanna Hayashi² 

[1] Department of Medicine, Faculty of Medicine, Chulalongkorn University, 254 Phayathai Road, Bangkok 10330, Thailand;Department of Medicine, Faculty of Medicine, University of British Columbia, 317-2194 Health Sciences Mall, Vancouver, BC, Canada;School of Population and Public Health, University of British Columbia, 2206 East Mall, Vancouver, BC, Canada;Thai AIDS Treatment Action Group, 18/89 Vipawadee Rd,soi 40 Chatuchak, Bangkok 10900, Thailand

关键词: Thailand;    Peer-based intervention;    Compulsory drug detention;    Injection drug use;    ART;   

Others  :  1212296
DOI  :  10.1186/s13011-015-0013-6

 received in 2014-12-13, accepted in 2015-04-24,  发布年份 2015

【 摘 要 】

Background

Thailand has experienced a longstanding epidemic of HIV among people who inject drugs (PWID). However, antiretroviral treatment (ART) coverage among HIV-positive PWID has historically remained low. While ongoing drug law enforcement involving periodic police crackdowns is known to increase the risk of HIV transmission among Thai PWID, the impact of such drug policy approaches on the ART uptake has been understudied. Therefore, we sought to identify factors associated with not receiving ART among HIV-positive PWID in Bangkok, Thailand, with a focus on factors pertaining to drug law enforcement.

Methods

Data were collected from a community-recruited sample of HIV-positive PWID in Bangkok who participated in the Mitsampan Community Research Project between June 2009 and October 2011. We identified factors associated with not receiving ART at the time of interview using multivariate logistic regression.

Results

In total, 128 HIV-positive PWID participated in this study, with 58 (45.3%) reporting not receiving ART at the time of interview. In multivariate analyses, completing less than secondary education (adjusted odds ratio [AOR]: 3.32 ; 95% confidence interval [CI]: 1.48 – 7.45), daily midazolam injection (AOR: 3.22, 95% CI: 1.45 – 7.15) and exposure to compulsory drug detention (AOR: 3.36, 95% CI: 1.01 – 11.21) were independently and positively associated with not receiving ART. Accessing peer-based healthcare information or support services was independently and positively associated with receiving ART (AOR: 0.21, 95% CI: 0.05 – 0.84).

Conclusions

Approximately half of our study group of HIV-positive PWID reported not receiving ART at the time of interview. Daily midazolam injectors, those with lower education attainment, and individuals who had been in compulsory drug detention were more likely to be non-recipients of ART whereas those who accessed peer-based healthcare-related services were more likely to receive ART. These findings suggest a potentially adverse impact of compulsory drug detention and highlight the need to expand interventions to facilitate access to ART among HIV-positive PWID in this setting.

【 授权许可】

   
2015 Hayashi et al.; licensee BioMed Central.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]Mathers BM, Degenhardt L, Phillips B, Wiessing L, Hickman M, Strathdee SA et al.. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008; 372(9651):1733-45.
• [2]The gap report. Joint United Nations Program on HIV/AIDS. Joint United Nations Programme on HIV/AIDS, Geneva; 2014.
• [3]HIV in Asia and the Pacific: getting to zero. Joint United Nations Programme on HIV/AIDS, Geneva; 2010.
• [4]Hogg RS, O'Shaughnessy MV, Gataric N, Yip B, Craib K, Schechter MT et al.. Decline in deaths from AIDS due to new antiretrovirals. Lancet. 1997; 349(9061):1294.
• [5]Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet. 2011; 367(9513):817-24.
• [6]Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N et al.. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011; 365(6):493-505.
• [7]Mathers BM, Degenhardt L, Ali H, Wiessing L, Hickman M, Mattick RP et al.. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet. 2010; 375(9719):1014-28.
• [8]Wolfe D, Carrieri MP, Shepard D. Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward. Lancet. 2010; 376(9738):355-66.
• [9]Milloy MJ, Montaner J, Wood E. Barriers to HIV treatment among people who use injection drugs: implications for “treatment as prevention”. Curr Opin HIV AIDS. 2012; 7(4):332-8.
• [10]Milloy MJ, Kerr T, Buxton J, Rhodes T, Guillemi S, Hogg R et al.. Dose–response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. J Infect Dis. 2011; 203(9):1215-21.
• [11]Pearshouse R. Compulsory drug treatment in Thailand: observations on the Narcotic Addict Rehabilitation Act B.E. 2545 (2002). Canadian HIV/AIDS Legal Network, Toronto; 2009.
• [12]Cohen JE, Amon JJ. Health and human rights concerns of drug users in detention in Guangxi Province. China PLoS Med. 2008; 5(12): Article ID e234
• [13]Wolfe D, Saucier R. In rehabilitation's name? Ending institutionalised cruelty and degrading treatment of people who use drugs. Int J Drug Policy. 2010; 21(3):145-8.
• [14]International Labour Organisation, Office of the High Commissioner for Human Rights, United Nations Development Programme, United Nations Educational, Scientific and Cultural Organization, United Nations Population Fund, United Nations High Commissioner for Refugees, et al. Joint statement: compulsory drug detention and rehabilitation centres. 2012. http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/document/2012/JC2310_Joint%20Statement6March12FINAL_en.pdf. Accessed 1 Apr 2015.
• [15]Thailand narcotics control annual report 2011. Office of the Narcotics Control Board, Ministry of Justice, Thailand, Bangkok; 2011.
• [16]National AIDS Prevention and Alleviation Committee. UNGASS country progress report Thailand: reporting period: January 2008 - December 2009. 2010. http://data.unaids.org/pub/Report/2010/thailand_2010_country_progress_report_en.pdf. Accessed 1 Apr 2015.
• [17]Thai National AIDS Committee. 2012 Thailand AIDS response progress report. 2013. http://www.unaids.org/sites/default/files/en/dataanalysis/knowyourresponse/countryprogressreports/2012countries/ce_th_narrative_report.pdf. Accessed 1 Apr 2015.
• [18]Chasombat S, McConnell MS, Siangphoe U, Yuktanont P, Jirawattanapisal T, Fox K et al.. National expansion of antiretroviral treatment in Thailand, 2000–2007: program scale-up and patient outcomes. J Acquir Immune Defic Syndr. 2009; 50(5):506-12.
• [19]Sungkanuparph S, Techasathit W. Thai national guidelines for antiretroviral therapy in HIV-1 infected adults and adolescents 2010. Asian Biomed. 2011; 4(4):515.
• [20]Hayashi K, Montaner J, Kaplan K, Suwannawong P, Wood E, Qi J et al.. Low uptake of hepatitis C testing and high prevalence of risk behavior among HIV-positive injection drug users in Bangkok. Thailand J Acquir Immune Defic Syndr. 2011; 56(5):e133-5.
• [21]Kerr T, Hayashi K, Ti L, Kaplan K, Suwannawong P, Wood E. The impact of compulsory drug detention exposure on the avoidance of healthcare among injection drug users in Thailand. Int J Drug Policy. 2014; 25(1):171-4.
• [22]Hayashi K, Suwannawong P, Ti L, Kaplan K, Wood E, Kerr T. High rates of midazolam injection and associated harms in Bangkok. Thailand Addiction. 2013; 108(5):944-52.
• [23]Thai National AIDS Committee. 2014 Thailand AIDS response progress report. 2014. http://www.unaids.org/sites/default/files/country/documents//THA_narrative_report_2014.pdf. Accessed 1 Apr 2015.
• [24]Cohen MS, Smith MK, Muessig KE, Hallett TB, Powers KA, Kashuba AD. Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet. 2013; 382(9903):1515-24.
• [25]Global AIDS response progress reporting 2014: construction of core indicators for monitoring the 2011 United Nations Political Declaration on HIV and AIDS. Joint United Nations Programme on HIV/AIDS, Geneva; 2014.
• [26]Thai AIDS Treatment Action Group. Deadly denial: barriers to HIV/AIDS treatment for people who use drugs in Thailand. Human Rights Watch, New York; 2007.
• [27]Needle RH, Burrows D, Friedman SR, Dorabjee J, TouzÈ G, Badrieva L et al.. Effectiveness of community-based outreach in preventing HIV/AIDS among injecting drug users. Int J Drug Policy. 2005; 16 Suppl 1:45-57.
• [28]Chasombat S, Lertpiriyasuwat C, Thanprasertsuk S, Suebsaeng L, Lo YR. The national access to antiretroviral program for PHA (NAPHA) in Thailand. Southeast Asian J Trop Med Public Health. 2006; 37(4):704-15.
• [29]Stoicescu C, editor. The global state of harm reduction 2012: towards an integrated response. Harm Reduction International, London; 2012.
• [30]Kerr T, Hayashi K, Fairbairn N, Kaplan K, Suwannawong P, Zhang R et al.. Expanding the reach of harm reduction in Thailand: Experiences with a drug user-run drop-in centre. Int J Drug Policy. 2010; 21(3):255-8.
• [31]Chan KY, Stoove MA, Reidpath DD. Stigma, social reciprocity and exclusion of HIV/AIDS patients with illicit drug histories: a study of Thai nurses' attitudes. Harm Reduct J. 2008; 5:28. BioMed Central Full Text
• [32]Kiatying-Angsulee N, Kulsomboon V, Kittisopee T, Patcharapisarn N, Sriwiriyanuparb W, Sirisinsuk Y, et al. Midazolam use in injecting drug users (IDUs) in Bangkok: preliminary results of a qualitative study. The 15th International AIDS Conference. Bangkok, Thailand; 2004. Abstractno.WePeC6048.
• [33]Lintzeris N, Nielsen S. Benzodiazepines, methadone and buprenorphine: interactions and clinical management. Am J Addict. 2010; 19(1):59-72.
• [34]Darke S. Benzodiazepine use among injecting drug users: problems and implications. Addiction. 1994; 89(4):379-82.
• [35]Darke S. Self-report among injecting drug users: a review. Drug Alcohol Depend. 1998; 51(3):253-63.